Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 5/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.49 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | ECE1 | P42892 | 1/20 | 0.48 |
| ▸ | GLP1R | P43220 | 1/20 | 0.48 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.48 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31307267 | 0.92 | OPRM1 (0.56) | OPRL1OPRM1OPRD1KISS1ROPRK1 | |
| SCHEMBL31462020 | 0.89 | OPRM1 (0.55) | OPRM1OPRD1KISS1ROPRK1 | |
| SCHEMBL31462115 | 0.89 | OPRM1 (0.52) | OPRM1OPRD1KISS1ROPRK1 | |
| SCHEMBL31462043 | 0.89 | KISS1R (0.53) | OPRM1OPRD1KISS1ROPRK1 | |
| SCHEMBL29568969 | 0.86 | OPRL1 (0.49) | OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL31462010 | 0.86 | QRFPR (0.52) | OPRL1OPRM1OPRD1OPRK1QRFPR | |
| SCHEMBL31461954 | 0.86 | TFPI (0.52) | OPRM1OPRD1KISS1ROPRK1 | |
| SCHEMBL9149411 | 0.85 | NPY4R (0.49) | OPRL1OPRM1OPRD1OPRK1QRFPR | |
| SCHEMBL31462110 | 0.85 | QRFPR (0.55) | OPRM1OPRD1KISS1ROPRK1QRFPR | |
| SCHEMBL9149396 | 0.85 | NPY4R (0.49) | OPRL1OPRM1OPRD1OPRK1QRFPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118613284-A | Compositions and methods for oral administration | 想象制药有限责任公司 | 2024-09-06 | — | — | CN | disclosed |